Elizabeth Head

Active 1994–2025

197
Papers
30,288
Citations
94
h-index
181
i10-index

Citations

Citations per year for Elizabeth Head1995: 3 citations1996: 16 citations1997: 9 citations1998: 11 citations1999: 10 citations2000: 41 citations2001: 48 citations2002: 96 citations2003: 88 citations2004: 186 citations2005: 206 citations2006: 253 citations2007: 213 citations2008: 309 citations2009: 316 citations2010: 381 citations2011: 411 citations2012: 403 citations2013: 370 citations2014: 369 citations2015: 389 citations2016: 332 citations2017: 367 citations2018: 306 citations2019: 978 citations2020: 1,094 citations2021: 1,066 citations2022: 837 citations2023: 672 citations2024: 1,204 citations2025: 730 citations2026: 11 citations

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 4,694 citing papers, 30.8% of this breakdownUnited Kingdom: 1,180 citing papers, 7.7% of this breakdownChina: 964 citing papers, 6.3% of this breakdownGermany: 801 citing papers, 5.3% of this breakdownItaly: 641 citing papers, 4.2% of this breakdownCanada: 609 citing papers, 4% of this breakdownSpain: 515 citing papers, 3.4% of this breakdownAustralia: 469 citing papers, 3.1% of this breakdownFrance: 448 citing papers, 2.9% of this breakdownNetherlands: 429 citing papers, 2.8% of this breakdownSweden: 415 citing papers, 2.7% of this breakdownJapan: 345 citing papers, 2.3% of this breakdown
0%30.8%Other 24.5%

Fields

  • Medicine53.9%
  • Biochemistry, Genetics and Molecular Biology23.4%
  • Neuroscience14.9%
  • Psychology1.8%
  • Immunology and Microbiology1%
  • Nursing0.9%
  • Other4.1%

Topics

  • Alzheimer's disease research and treatments15.1%
  • Neuroinflammation and Neurodegeneration Mechanisms4.6%
  • Dementia and Cognitive Impairment Research3.7%
  • Cholinesterase and Neurodegenerative Diseases2.3%
  • Computational Drug Discovery Methods2.2%
  • Genetic Associations and Epidemiology2%
  • Other70.1%

Coauthors

All papers

Open in search
  1. Single-nucleus chromatin accessibility and transcriptomic characterization of Alzheimer’s disease

    Authors: , , , , , , , , , - Nature Genetics 2021 cited by 706

  2. Cholesterol and matrisome pathways dysregulated in astrocytes and microglia

    Authors: , , , , , , , , , , , , , , , , , , , , - Cell 2022 cited by 416

  3. Analysis of shared heritability in common disorders of the brain

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , M. Ilyas Kamboh, Eric B. Larson, Ekaterina Rogaeva, Peter St George‐Hyslop, Håkon Håkonarson, Walter A. Kukull, Lindsay A. Farrer, Lisa L. Barnes, Thomas G. Beach, F. Yesim Demirci, Elizabeth Head, Christine M. Hulette, Gregory A. Jicha, John S.K. Kauwe, Jeffrey A. Kaye, James B. Leverenz, Allan I. Levey, Andrew P. Lieberman, V. Shane Pankratz, Wayne W. Poon, Joseph F. Quinn, Andrew J. Saykin, Lon S. Schneider, Amanda Smith, Joshua A. Sonnen, Robert A. Stern, Vivianna M. Van Deerlin, Linda J. Van Eldik, Denise Harold, Giancarlo Russo, David C. Rubinsztein, Anthony Bayer, Magda Tsolaki, Petra Proitsi, Nick C. Fox, Harald Hampel, Michael J. Owen, Simon Mead, Peter Passmore, Kevin Morgan, Markus M. Nöthen, Jonathan M. Schott, Martin N. Rossor, Michelle K. Lupton, Per Hoffmann, Johannes Kornhuber, Brian Lawlor, Andrew McQuillin, Ammar Al‐Chalabi, Joshua C Bis, Agustı́n Ruiz, Merçé Boada, Sudha Seshadri, Alexa Beiser, Kenneth Rice, Sven J. van der Lee, Philip L. De Jager, Daniel H. Geschwind, Matthias Riemenschneider, Steffi G. Riedel‐Heller, Jerome I. Rotter, Gerhard Ransmayr, Bradley T. Hyman, Carlos Cruchaga, Montserrat Alegret, Bendik S. Winsvold, Priit Palta, Kai-How Farh, Ester Cuenca-León, Nicholas A. Furlotte and 477 more - Science 2018 cited by 2,050

  4. Common variants at MS4A4/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer's disease

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Robert C. Green, Ekaterina Rogaeva, Peter St George‐Hyslop, Steven E. Arnold, Robert C. Barber, Thomas G. Beach, Eileen H. Bigio, James D. Bowen, Adam Boxer, James R. Burke, Nigel J. Cairns, Chris Carlson, Regina M. Carney, Steven L. Carroll, Helena C. Chui, David G. Clark, Jason J. Corneveaux, Carl W. Cotman, Jeffrey L. Cummings, Charles DeCarli, Steven T. DeKosky, Ramon Diaz‐Arrastia, Malcolm Dick, Dennis W. Dickson, William G. Ellis, Kelley M. Faber, Kenneth B. Fallon, Martin R. Farlow, Steven H. Ferris, Matthew P. Frosch, Douglas Galasko, Mary Ganguli, Marla Gearing, Daniel H. Geschwind, Bernardino Ghetti, John R. Gilbert, Sid Gilman, Bruno Giordani, Jonathan D. Glass, John H. Growdon, Ronald L. Hamilton, Lindy E. Harrell, Elizabeth Head, Lawrence S. Honig, Christine M. Hulette, Bradley T. Hyman, Gregory A. Jicha, Lee‐Way Jin, Nancy Johnson, Jason Karlawish, Anna Karydas, Jeffrey Kaye, Ronald Kim, Edward H. Koo, Neil W. Kowall, James J. Lah, Allan I. Levey, Andrew P. Lieberman, Oscar L. López, Wendy J. Mack, Daniel Marson, Frank Martiniuk, Deborah C. Mash, Eliezer Masliah, Wayne C. McCormick, Susan M. McCurry, Andrew McDavid, Ann C. McKee, Marsel Mesulam, Bruce L. Miller and 55 more - Nature Genetics 2011 cited by 2,014

  5. Alzheimer's disease associated with Down syndrome: a genetic form of dementia

    Authors: , , , , , - The Lancet Neurology 2021 cited by 352

  6. Perspectives on ethnic and racial disparities in Alzheimer's disease and related dementias: Update and areas of immediate need

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Krista L. Lanctôt, Jennifer J. Manly, Ralph N. Martins, Michelle M. Mielke, Martha Clare Morris, Melissa E. Murray, Esther S. Oh, Mario A. Parra, Robert A. Rissman, Catherine M. Roe, Octavio A. Santos, Nikolaos Scarmeas, Lon S. Schneider, Nicole Schupf, Sietske A.M. Sikkes, Heather M. Snyder, Hamid R. Sohrabi, Yaakov Stern, André Strydom, Yi Tang, Graciela Muñiz‐Terrera, Charlotte E. Teunissen, Debora Melo van Lent, Michael Weinborn, Linda M.P. Wesselman, Donna M. Wilcock, Henrik Zetterberg, Sid E. O’Bryant - Alzheimer s & Dementia 2018 cited by 539

  7. Common Structure of Soluble Amyloid Oligomers Implies Common Mechanism of Pathogenesis

    Authors: , , , , , , - Science 2003 cited by 4,088

  8. Absence of microglia promotes diverse pathologies and early lethality in Alzheimer’s disease mice

    Authors: , , , , , , , , , , , , , , , , , , , , - Cell Reports 2022 cited by 182

  9. Dementia in Down syndrome: unique insights for Alzheimer disease research

    Authors: , - Nature Reviews Neurology 2019 cited by 381

  10. Type-I-interferon signaling drives microglial dysfunction and senescence in human iPSC models of Down syndrome and Alzheimer’s disease

    Authors: , , , , , , , , , , , , , , , - Cell stem cell 2022 cited by 166

  11. Down Syndrome, Partial Trisomy 21, and Absence of Alzheimer’s Disease: The Role of APP

    Authors: , , , , , , , , , - Journal of Alzheimer s Disease 2016 cited by 259

  12. Gene expression changes in the course of normal brain aging are sexually dimorphic

    Authors: , , , , , , , , , , , - National Academy of Sciences, Proceedings of the National Academy of Sciences 2008 cited by 650

  13. Fibril specific, conformation dependent antibodies recognize a generic epitope common to amyloid fibrils and fibrillar oligomers that is absent in prefibrillar oligomers

    Authors: , , , , , , , , , , , , , - Molecular Neurodegeneration 2007 cited by 782

  14. The Alzheimer's Biomarker Consortium‐Down Syndrome: Rationale and methodology

    Authors: , , , , , , , , , , , , , , , , , , , , , - Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring 2020 cited by 119

  15. Aging in Down Syndrome and the Development of Alzheimer's Disease Neuropathology

    Authors: , , , - Current Alzheimer Research 2015 cited by 289

  16. Cerebral amyloid angiopathy in Down syndrome and sporadic and autosomal‐dominant Alzheimer's disease

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , - Alzheimer s & Dementia 2017 cited by 90

  17. Spatial and single-nucleus transcriptomic analysis of genetic and sporadic forms of Alzheimer’s disease

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , - Nature Genetics 2024 cited by 82

  18. Comparison of amyloid burden in individuals with Down syndrome versus autosomal dominant Alzheimer's disease: a cross-sectional study

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Howard Andrews, Karen L. Bell, Rasmus M. Birn, Peter Bulova, Amrita K. Cheema, Kewei Chen, I. C. H. Clare, Lorraine N. Clark, Ann D. Cohen, John N. Constantino, Eric Doran, Eleanor Feingold, Tatiana Foroud, Sigan L. Hartley, Christy Hom, Lawrence S. Honig, Miloš D. Ikonomović, Sterling C. Johnson, Courtney Jordan, M. Ilyas Kamboh, David B. Keator, William E. Klunk, Julia Kofler, William Charles Kreisl, Sharon J Krinsky- McHale, Patrick J. Lao, Charles M. Laymon, Ira T. Lott, Victoria Lupson, Chester A. Mathis, Davneet Minhas, Neelesh Nadkarni, Deborah Pang, Melissa Petersen, Julie C. Price, Margaret Pulsifer, Eric M. Reiman, Batool Rizvi, Marwan N. Sabbagh, Nicole Schupf, Dana Tudorascu, Rameshwari V. Tumuluru, Benjamin Tycko, Badri Varadarajan, Desirée A. White, Michael A. Yassa, Shahid Zaman, Fan Zhang, Sarah Adams, Ricardo Allegri, Aki Araki, Nicolas R. Barthélemy, Jacob Bechara, Sarah Berman, Courtney Bodge, Susan E. Brandon, William S. Brooks, Jared R. Brosch, Jill Buck, Virginia Buckles, Kathleen Carter, Lisa Cash, Patricio Chrem Méndez, Jasmin Chua, Helena C. Chui, Laura Courtney, Gregory S. Day, Chrismary DeLaCruz, Darcy Denner, Anna Diffenbacher and 101 more - The Lancet Neurology 2022 cited by 56

  19. Further understanding the connection between Alzheimer's disease and Down syndrome

    Authors: , , , , , , , , , , , , , , , , , , , , , , , - Alzheimer s & Dementia 2020 cited by 103

  20. Cerebrovascular pathology in Down syndrome and Alzheimer disease

    Authors: , , , , , , - Acta Neuropathologica Communications 2017 cited by 109

  21. Opportunities, barriers, and recommendations in Down syndrome research

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Bernard Khor, Jeanne B. Lawrence, Catherine Lemonnier, Amy Feldman Lewanda, William C. Mobley, Paul E. Moore, Linda Nelson, Nicolas M. Oreskovic, Ricardo S. Osorio, David Patterson, Sonja A. Rasmussen, Roger H. Reeves, Nancy Roizen, Stephanie L. Santoro, Stephanie L. Sherman, Nasreen Talib, Ignacio E. Tapia, Kyle M. Walsh, Steven F. Warren, A. Nicole White, G. William Wong, John S. Yi - Translational Science of Rare Diseases 2021 cited by 99

  22. Diagnostic and prognostic performance and longitudinal changes in plasma neurofilament light chain concentrations in adults with Down syndrome: a cohort study

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , - The Lancet Neurology 2021 cited by 63

  23. Alzheimer’s disease is not “brain aging”: neuropathological, genetic, and epidemiological human studies

    Authors: , , , , , , , , , , - Acta Neuropathologica 2011 cited by 361

  24. Characterization of hippocampal sclerosis of aging and its association with other neuropathologic changes and cognitive deficits in the oldest-old

    Authors: , , , , , , , , , - Acta Neuropathologica 2023 cited by 34